These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8480059

  • 21. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA, Rith-Najarian SJ, McIntyre MC, Ross C, Dahl DC, Keane WF, Kasiske BL.
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [Abstract] [Full Text] [Related]

  • 22. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C, Thamprasit A, Leelawattana R, Soonthornpun S, Setasuban W.
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [Abstract] [Full Text] [Related]

  • 23. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B.
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [Abstract] [Full Text] [Related]

  • 24. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF.
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [Abstract] [Full Text] [Related]

  • 25. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E, Sabuncu T, Ozer EM, Hatemi H.
    J Diabetes Complications; 2005 Jan; 19(5):254-8. PubMed ID: 16112499
    [Abstract] [Full Text] [Related]

  • 26. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T, Likitmaskul S, Plengvidhya N, Suwanwalaikorn S, Kosachunhanun N, Deerochanawong C, Krittiyawong S, Leelawatana R, Benjasuratwong Y, Bunnag P, Prathipanawatr T, Ngarmukos C, Mongkolsomlit S, Rawdaree P.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [Abstract] [Full Text] [Related]

  • 27. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
    Gorus FK.
    Verh K Acad Geneeskd Belg; 1996 Aug; 58(5):539-86. PubMed ID: 9008403
    [Abstract] [Full Text] [Related]

  • 28. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C, Ramachandran A, Mohan V, Viswanathan M.
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [Abstract] [Full Text] [Related]

  • 29. [Study of lymphocyte subpopulations and the expression of activation markers in diabetes mellitus types 1 and 2].
    Salozhin KV, Nasonov EL, Sura VV, Aleksandrova EN, Gracheva LA.
    Klin Med (Mosk); 1989 Oct; 67(10):118-21. PubMed ID: 2693822
    [Abstract] [Full Text] [Related]

  • 30. Diabetes mellitus in the elderly.
    Singh I, Marshall MC.
    Endocrinol Metab Clin North Am; 1995 Jun; 24(2):255-72. PubMed ID: 7656891
    [Abstract] [Full Text] [Related]

  • 31. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Betrams J, Kolb H.
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [Abstract] [Full Text] [Related]

  • 32. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC.
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [Abstract] [Full Text] [Related]

  • 33. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
    Colman PG, Harrison LC, Tait BD.
    Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215
    [Abstract] [Full Text] [Related]

  • 34. Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
    Girelli CM, Reguzzoni G, Limido E, Savastano A, Rocca F.
    Recenti Prog Med; 1995 Apr; 86(4):143-6. PubMed ID: 7617956
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Diabetes and immunology. I. Immunologic reactions linked to diabetes].
    Ekoe JM, Albert J.
    Sem Hop; 1983 May 26; 59(21):1630-2. PubMed ID: 6310778
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Insulin dependence: problems with the classification of 100 consecutive patients.
    Wilson RM, Van der Minne P, Deverill I, Heller SR, Gelsthrope K, Reeves WG, Tattersall RB.
    Diabet Med; 1985 May 26; 2(3):167-72. PubMed ID: 2952412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.